Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tracheal External Support Using a Parallel Loop Line Prosthesis for Tracheal Stent Fracture in a Dog: A Case Report.

Animals : an open access journal from MDPI·2026
Same author

International Survey on Genetic Literacy and Awareness in Patients With Spinal and Bulbar Muscular Atrophy.

Neurology. Genetics·2026
Same author

Study of Imaging Analysis for Distinguishing Alveolar Collapse From Invasive Lesions in Early-Stage Lung Adenocarcinoma.

Thoracic cancer·2026
Same author

Translational Advances in Urothelial Carcinoma: From Bench to Bedside.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Safety and efficacy of preoperative chemotherapy for obstructive colon cancer with endoscopic stenting: SUCCEED study.

Future oncology (London, England)·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

相关实验视频

Updated: Jun 29, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

用基于源的形态测量在神经认知障碍中的amyloid-β预测机器学习模型.

Yuki Momota1,2, Shogyoku Bun3, Jinichi Hirano4

  • 1Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.

Scientific reports
|April 1, 2024
PubMed
概括
此摘要是机器生成的。

这项研究开发了一种机器学习模型,使用MRI扫描和临床数据来预测粉样蛋白β沉积,有助于阿尔茨海默病.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.粉样蛋白-β 是一种机器学习是机器学习.磁共振成像技术 磁共振成像技术基于源的形态测量方法

更多相关视频

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.3K
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K

相关实验视频

Last Updated: Jun 29, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.3K
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K

科学领域:

  • 神经成像是一种神经成像.
  • 机器学习 机器学习
  • 神经学 神经学

背景情况:

  • 使用磁共振成像 (MRI) 的机器学习 (ML) 模型已被用于阿尔茨海默病 (AD) 预测.
  • 对于这些预测模型,有限的研究集中在不同患者群体上.
  • 准确预测粉样β (Aβ) 沉积对于神经退行性疾病的早期诊断和干预至关重要.

研究的目的:

  • 开发一种临床上有用的ML模型,用于使用基于源形态测量 (SBM) 预测Aβ沉积.
  • 评估结合不同特征 (MRI,认知测试,阿波利波蛋白E状态) 对预测准确性的影响.
  • 评估模型在多样化的队列中的表现,包括AD,其他神经障碍,精神疾病和健康对照.

主要方法:

  • 利用了来自118名具有各种神经学,精神病诊断和健康对照者的结构性MRI数据.
  • 在SBM中使用独立组件分析 (ICA) 来从基于voxel的灰色物质图像中获得数据驱动的特征.
  • 使用支向量机 (SVM) 分类器和夏普利添加式解释 (SHAP) 进行模型解释性和问责制.

主要成果:

  • 综合MRI,认知测试和阿波利波蛋白E状态的综合模型实现了89.8%的准确性 (AUC 0.888).
  • 一个仅使用MRI的模型显示准确率为84.7%,突出显示了临床数据的附加值.
  • 该模型准确地检测了非AD患者的Aβ阳性,并预测了各种疾病的Aβ阳性,准确度中等至高.

结论:

  • 基于MRI的数据驱动的ML方法,结合临床数据,可以有效地预测Aβ沉积在广泛的神经和精神疾病的范围.
  • 基于源的形态测量确定了与AD相关的特定灰色物质模式,对预测准确性作出了重大贡献.
  • 这种ML模型显示出有希望作为一种有价值的诊断辅助工具来识别Aβ病理,潜在地改善早期检测和患者管理.